Abstract:Objectives Transforming growth factor-β1 (TGF-β1) is one of the key mediators of the peritoneal fibrosis. Short hairpin RNAs (shRNA) transcribed by vectors contained U6 or H1 promoter can trigger sequenceselective gene silencing in mammalian cells. This study investigated the effects of shRNA targeting TGF-β1 on the expression of TGF-β1 and ultrastructure in human peritoneal mesohelial cells (HPMCs) induced by peritoneal dialysis solution (PD solution). Methods All tests were performed on the human peritoneal mesothelial cell (HMrSV5). TGF- β1 specific shRNA expression vectors were constructed and introduced to HPMCs stimulated with two commercially available PD solution (1.50% and 4.25% Dianeal) or DMEM to 48h. The dialysis solutions were diluted twofold with DMEM. Expression of TGF-β1 mRNA was detected by semiquantitative reverse transcription polymerase chain reaction (RT-PCR). The TGF-β1 protein level in the culture supernatant was analyzed by enzyme-linked immunosorbent assay. Ultrastructure changes of HPMCs were observed by transmission electron microscopy. Results The expression of TGF-β1 was upregulated significantly in HPMCs stimulated with 4.25% PD solution (P 0.01). TGF-β1 expression in pcDU6 plasmid vector-mediated shRNA group were obviously downregulated when compared to the 4.25% PD solution group and the pcDU6 void vector group (P 0.01), with no significant difference among pcDU6 plasmid vector-mediated shRNA groups (P 0.01). Ultrastructural studies of HPMCs exposed to 4.25% PD solution showed cell flattening, reduced microvilli, and intracellular organelles compatible with dysfunctional mitochondria. In contrast, the ultrastructural morphology of HPMCs was relatively preserved after introduction with TGF-β1 shRNA vectors. Conclusions TGF-β1 specific shRNA can significantly inhibit the expresson of TGF-β1 and ameliorates the ultrastructural abnormalities in HPMCs stimulated with 4.25% PD solution. Our results of this in vitro study suggest that TGF- β1 specific shRNA expression vectors transfer might be of the therapeutic benefit in peritoneal fibrosis. However,further studies in vivo are needed to confirm this hypothesis.

Puerarin protects the cultured human peritoneal mesothelial cells from the damage caused by peritoneal dialysate

The Effect of Puerarin on the Oxidative Stress in Cultured Human Peri-toneal Mesothelial Cells

Effects of Short Hairpin RNAs on TGF-β1 Expression and Ultrastructure in HPMCs Induced by Peritoneal Dialysis Solution

Puerarin protects human umbilical vein endothelial cells against high glucose-induced apoptosis by upregulating heme oxygenase-1 and inhibiting calpain activation.

Effect of Glucose Related to Peritoneal Dialysate on the Cell Cycle and Protein P21 Expression in Human Peritoneal Mesothelial Cells and the Antagonism of Puerarin

Puerarin Ameliorates Oxidative Stress in Patients Undergoing Continuous Ambulatory Peritoneal Dialysis

Puerarin protects PC12 cells injury induced by hydrogen peroxide in culture

Effect of Puerarin on Oxidative Stress in Continuous Ambulatory Peritoneal Dialysis Patients

Effects of Astragalus on Secretion and Mrna Expression of TGF-β1 Induced by Peritoneal Dialysis Solution in Cultured Human Peritoneal Mesothelial Cell

Effect of Pentoxifylline on Human Peritoneal Mesothelial Cells' Function and TGF-β1, FN Secretion Induced by Lactate-buffered Peritoneal Dialysis Solutes

Effect of Glucose Related to Peritoneal Dialysate on Telomere Length in Human Peritoneal Mesothelial Cells and Protection of Puerarin

Effects of Astragalus on the apoptosis of cultured human peritoneal mesothelium induced by peritoneal dialysis solution

Inhibition Effect of Puerarin on the Formation of Advanced Glycosylation End Products in Peritoneal Dialysis Solution in Vitro

Astragalus Mongholicus Altered the Secretion and Expression of Transforming Growth Factor-Β1 and Basic Fibroblast Growth Factor in Cultured Human Peritoneal Mesothelial Cells

[The Effect of Lactate-Buffered Peritoneal Dialysis Fluid in Human Peritoneal Mesothelial Cells Function].

Investigation of the Apoptosis of Cultured Human Peritoneal Mesothelial Cells Induced by Peritoneal Dialysis Solution

Puerarin Protects Against Cardiac Fibrosis Associated with the Inhibition of TGF-β1/Smad2-Mediated Endothelial-to-Mesenchymal Transition.

The Effect of Tanshinone ⅡA on the Secretion and Expression of VEGF and TGF-β1 in Cultured Human Peritoneal Mesothelial Cells

Effects of tanshinoneⅡA on oxidative stress and apoptosis cytokine expression of human peritoneal mesothelial cells

The effect of puerarin on the damage of osteoblasts induced by hydrogen peroxide

Sulfotanshinone ⅡA Sodium Ameliorates Lipopolysaccharide-Peritoneal Dialysis Solution-Elicited Human Peritoneal Mesothelial Cells Injury